StatStrip 1.0 (REF 43773)Recalls & reported problems
Nova Biomedical Corporation · StatStrip GLU Meter and Quick Reference Guide Remanufactured · Class 1
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00385480437738), received between Feb 15, 2017 and Feb 16, 2017 — classified as 2 malfunctions.
The most frequently reported specific device problem is “High Readings” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- High Readings1
- Incorrect Or Inadequate Test Results1
- Incorrect, Inadequate or Imprecise Result or Readings1
Patient problems
- No Known Impact Or Consequence To Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionFeb 16, 2017Incorrect Or Inadequate Test Results
RECEIVED USER-FACILITY REPORT # (B)(4): ROUTINE POC BLOOD GLUCOSE RESULT OF "HI". BLOOD SUGAR RECHECKED WITH DIFFERENT GLUCOMETER WITH READING OF 151.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 6335934 ↗MalfunctionFeb 15, 2017Incorrect, Inadequate or Imprecise Result or Readings; High Readings
USER-FACILITY MEDWATCH REPORT # (B)(4) RECEIVED "CHECKED PATIENT GLUCOSE PRIOR TO DINNER AND READING WAS 481. PATIENT HAS NOT BEEN HAVING HIGH GLUCOSE. RECHECKED THE GLUCOSE AFTER 1 MINUTE AND READING WAS 280 WITH SAME GLUCOMETER WITHOUT ANY INTERVENTIONS. GLUCOMETER TAKEN OUT OF SERVICE."
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 6333065 ↗
Other Single (specified) analyte controls (assayed and unassayed) devices
- CONTOUR® NEXT 7314Ascensia Diabetes Care US Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)227 reports
- FastPack® IP SHBG FastPack® IP SHBG 30 ImmunoassayQualigen Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)2 recalls0 reports
- CONTOUR® NEXT 7377Ascensia Diabetes Care US Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)95 reports
- ARCHITECT 7K62-25Abbott Ireland · SINGLE (SPECIFIED) ANALYTE CONTROLS (ASSAYED AND UNASSAYED)94 reports
- ARCHITECT 08K2812Abbott GmbH · Single (specified) analyte controls (assayed and unassayed)1 recall12 reports
- CONTOUR® NEXT 9697Ascensia Diabetes Care US Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)56 reports
- VITROS 6192257Ortho Clinical Diagnostics · Single (specified) analyte controls (assayed and unassayed)1 recall0 reports
- McKesson 5011Mckesson Medical-Surgical Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)1 recall0 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.